Sector Chart Ocugen, Inc.

Equities

OCGN

US67577C1053

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 10:16:43 10/04/2026 pm IST			5-day change	1st Jan Change
1.795 ^USD	-4.01%		+1.69%	+33.33%

01/04	Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of Ocu410st for Stargardt Disease	CI
01/04	Ocugen Completes Enrollment, Dosing for Phase 2/3 Eye Disorder Treatment Trial; Shares Up Pre-Bell	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
OCUGEN, INC.	63Cr			-	-	-
LONZA GROUP AG	4.47TCr
BEONE MEDICINES AG	3.48TCr
CELLTRION, INC.	2.98TCr
IQVIA HOLDINGS INC.	2.84TCr
REVOLUTION MEDICINES, INC.	1.91TCr	-	-	-	-	-